4
Changes in Ownership
Cartesian Therapeutics, Inc. Filed Acc 0001453687-20-000010
Options or other derivatives
- Chief Financial Officer acquired 140,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Dahms Bradford D. · Chief Financial Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2020-01-02 | Grant or award : show line 1 in the form Employee Stock Option (right to buy) | +140,000 | $2.30 | 2030-01-01 | 140,000 | 140,000 | D |
Loading xslF345X03/wf-form4_157835920999505.xml…